Adres: Abdi Ipekçi Caddesi No:40 Kat:1 D.6-7 (Rolex Saat Üstü) Nisantaşı /Istanbul

Botulinum Toxin Procedure in Migraine Treatment

Migren Tedavisinde Botulinum Toksin Uygulamasi

Migraine and Botulinum Toxin

In migraine, the pathology that begins with the contraction of some blood vessels in the brain reaches the muscles and turns into severe headache. Various types of treatments are available for migraine experienced as pain attacks. Injection of botulinum toxin is one of the popular treatment alternatives preferred in recent years. With studies and practices, it has been shown that Botulinum Toxin injection significantly reduces the severity and frequency of migraine attacks and tension-type headaches. The FDA has approved Botulinum Toxin as a preventative treatment option for chronic migraine.

The toxin secreted by a bacterium called “Clostridium botulinum” in Latin is weakened in laboratory environment, and the resultant form, which is therapeutic for humans, is called botulinum toxin. It is safely used by physiotherapists, neurologists, orthopedics and ophthalmologists for the treatment of various diseases. We use it most commonly for the treatment of wrinkles in aesthetic dermatology. Its positive contribution to migraine treatment is another effect of it discovered in recent years.

Botulinum Toxin and Expectations Afterwards

We treat migraine with botulinum toxin with the fine-needle injections like in aesthetic procedures.   We determine the trigger points of migraine and plan the points to be injected. The dose we apply is 2-3 times more than the dose used for aesthetic purposes. In addition headaches, botulinum toxin administration for migraine also offers a solution for wrinkles on the forehead and between the eyebrows. Neurotransmission of the injection area is blocked immediately with botulinum toxin injection. Thus, a treatment is obtained for migraine attacks. The pain of chronic migraine is relieved significantly 3-7 days after the procedure. The effect of the treatment lasts for about 6 months. On the 12th week, one more administration is advised for these patients.